-
Oncolytics Biotech Inc. is a
Canadian company headquartered in Calgary, Alberta, that is
developing an
intravenously delivered immuno-
oncolytic virus...
- An
oncolytic virus is a
virus that
preferentially infects and
kills cancer cells. As the
infected cancer cells are destro**** by oncolysis, they release...
- such as ICP34.5, ICP6/UL39, and ICP47. HSV1716 is a
first generation oncolytic virus developed by the
Glasgow Institute of Virology, and subsequently...
-
vector for gene
therapy and also as an
oncolytic virus. Of the many
different viruses being explored for
oncolytic potential, an
adenovirus was the first...
- Tong, Aiping; Yang, **** (2019). "
Oncolytic viruses for
cancer therapy:
barriers and
recent advances". Mol Ther
Oncolytics. 15: 234–247. doi:10.1016/j.omto...
-
Virotherapy "
Oncolytics Biotech Announces Publication of
Positive Clinical Results for
Pelareorep in
Abstract for ESMO 2018 Congress".
Oncolytics Biotech....
-
Talimogene laherparepvec is a
genetically engineered herpes virus (an
oncolytic herpes virus). Two
genes were
removed – one that
shuts down an individual...
-
researched as a
viral vector in gene
therapy for
cancer treatment as an
oncolytic virus.
Currently there are not any FDA
approved AAV
cancer treatments...
-
Herpes simplex research includes all
medical research that
attempts to prevent, treat, or cure herpes, as well as
fundamental research about the nature...
-
clinically tested as
oncolytic agents. T-Vec is the
first FDA-approved
oncolytic virus for the
treatment of melanoma. A
number of
other oncolytic viruses are in...
